Annual EPS
$27.85$93.22+142.61%
Summary
- Current Value
- As of today, BIO annual EPS is $27.85, up +142.61% on
- Historical Performance
- BIO annual EPS is up +122.87% over the past 3 years, down -77.93% over the past 5 years
- All-Time High Comparison
- BIO annual EPS is currently -80.22% below its historical high of $140.83 set on
- 3-Year Low Comparison
- BIO annual EPS is +122.87% above its 3-year low of -$121.79 reached on an earlier date
- Sector Comparison
- BIO annual EPS is higher than 99.20% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate BIO annual EPS at $9.48, -65.95% lower than the current value
- Upcoming Earnings
- As of today, the next annual earnings release for BIO has not been scheduled
EPS Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EPS | $27.85 | +142.6% | +122.9% | -77.9% | +322.7% | |
| Quarterly EPS | $13.85 | +18.7% | +135.0% | -54.3% | +882.3% | |
| TTM EPS | $8.25 | -29.7% | +155.2% | -93.8% | +25.6% | |
| Price | $386.11 | +33.4% | -2.1% | -52.9% | +296.7% | |
| Annual Revenue | $2.58B | +0.7% | -7.8% | +1.5% | +34.0% | |
| PE Ratio | 46.78 | +89.6% | – | +665.6% | +215.7% | |
| Annual Net Income | $759.90M | +141.2% | +121.0% | -80.0% | +306.5% | |
| Annual Gross Profit | $1.34B | -2.6% | -14.3% | -6.4% | +23.1% | |
| Shares Outstanding | 26.74M | -1.2% | -8.0% | -10.2% | – |
EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $27.85 | at high | |
| 5Y | $140.83 | -80.2% | |
| All | $140.83 | -80.2% |
EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$121.79 | N/A | +122.9% |
| 5Y | -$121.79 | +122.9% | |
| All | -$121.79 | +122.9% |
EPS Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $10.06 | -$65.36 | -749.63% | |
| $9.95 | $27.85 | +179.85% | |
| $9.48 | N/A | -65.95% | |
| $10.03 | N/A | -64.00% |
🔒 Log In To Unlock Full Data
EPS History
FAQ
- What is the current annual EPS of BIO?
- As of today, BIO annual EPS is $27.85
- What is 1-year change in BIO annual EPS?
- BIO annual EPS is up +142.61% year-over-year
- What is 3-year change in BIO annual EPS?
- BIO annual EPS is up +122.87% over the past 3 years
- How far is BIO annual EPS from its all-time high?
- BIO annual EPS is currently -80.22% below its historical high of $140.83 set on December 31, 2021
- How does BIO annual EPS rank versus sector peers?
- BIO annual EPS is higher than 99.20% of companies in Healthcare sector
- How does the analyst estimate for BIO annual EPS compare to its current value?
- Analysts estimate BIO annual EPS at $9.48, -65.95% lower than the current value
- When is BIO next annual earnings release?
- As of today, the next annual earnings release for BIO has not been scheduled
EPS Formula
EPS =
Quarterly EPS
$13.85$33.40+170.84%
Summary
- Current Value
- As of today, BIO quarterly EPS is $13.85, up +170.84% on
- Historical Performance
- BIO quarterly EPS is up +18.67% year-over-year, up +134.98% over the past 3 years
- All-Time High Comparison
- BIO quarterly EPS is currently -89.34% below its historical high of $129.96 set on
- 3-Year Low Comparison
- BIO quarterly EPS is +118.16% above its 3-year low of -$76.26 reached on
- Sector Comparison
- BIO quarterly EPS is higher than 99.81% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate BIO quarterly EPS at $2.23, -83.89% lower than the current value
- Upcoming Earnings
- The next earnings release for BIO is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EPS | $13.85 | +170.8% | +18.7% | +135.0% | -54.3% | |
| Annual EPS | $27.85 | – | +142.6% | +122.9% | -77.9% | |
| TTM EPS | $8.25 | +35.9% | -29.7% | +155.2% | -93.8% | |
| Price | $386.11 | +25.6% | +33.4% | -2.1% | -52.9% | |
| Quarterly Revenue | $651.00M | +9.9% | -0.1% | -4.4% | -9.1% | |
| PE Ratio | 46.78 | -7.6% | +89.6% | – | +665.6% | |
| Quarterly Net Income | $371.40M | +170.5% | +16.9% | +132.0% | -59.4% | |
| Quarterly Gross Profit | $345.80M | +11.8% | +0.1% | -5.5% | -14.1% | |
| Shares Outstanding | 26.74M | – | -1.2% | -8.0% | -10.2% |
Quarterly EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $26.65 | -48.0% | |
| 3Y | $26.65 | -48.0% | |
| 5Y | $129.96 | -89.3% | |
| All | $129.96 | -89.3% |
Quarterly EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$19.55 | +170.8% | |
| 3Y | -$76.26 | +118.2% | |
| 5Y | -$112.50 | +112.3% | |
| All | -$112.50 | +112.3% |
Quarterly EPS Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.99 | -$19.55 | -1,084.97% | |
| $1.75 | $13.85 | +693.66% | |
| $2.23 | N/A | -83.89% | |
| $2.91 | N/A | -79.01% |
🔒 Log In To Unlock Full Data
Quarterly EPS History
FAQ
- What is the current quarterly EPS of BIO?
- As of today, BIO quarterly EPS is $13.85
- What is BIO quarterly EPS most recent change?
- BIO quarterly EPS was up +170.84% on June 30, 2026
- What is 1-year change in BIO quarterly EPS?
- BIO quarterly EPS is up +18.67% year-over-year
- How far is BIO quarterly EPS from its all-time high?
- BIO quarterly EPS is currently -89.34% below its historical high of $129.96 set on September 30, 2021
- How does BIO quarterly EPS rank versus sector peers?
- BIO quarterly EPS is higher than 99.81% of companies in Healthcare sector
- How does the analyst estimate for BIO quarterly EPS compare to its current value?
- Analysts estimate BIO quarterly EPS at $2.23, -83.89% lower than the current value
- When is BIO next earnings release?
- The next earnings release for BIO is on
EPS Formula
EPS =
TTM EPS
$8.25$2.18+35.87%
Summary
- Current Value
- As of today, BIO TTM EPS is $8.25, up +35.87% on
- Historical Performance
- BIO TTM EPS is down -29.66% year-over-year, up +155.15% over the past 3 years
- All-Time High Comparison
- BIO TTM EPS is currently -96.26% below its historical high of $220.48 set on
- 3-Year Low Comparison
- BIO TTM EPS is +110.83% above its 3-year low of -$76.20 reached on
- Sector Comparison
- BIO TTM EPS is higher than 96.53% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate BIO TTM EPS at $23.18, +180.88% higher than the current value
- Upcoming Earnings
- The next earnings release for BIO is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EPS | $8.25 | +35.9% | -29.7% | +155.2% | -93.8% | |
| Quarterly EPS | $13.85 | +170.8% | +18.7% | +135.0% | -54.3% | |
| Annual EPS | $27.85 | – | +142.6% | +122.9% | -77.9% | |
| Price | $386.11 | +25.6% | +33.4% | -2.1% | -52.9% | |
| TTM Revenue | $2.59B | -0.0% | +1.4% | -6.5% | -10.1% | |
| PE Ratio | 46.78 | -7.6% | +89.6% | – | +665.6% | |
| TTM Net Income | $222.40M | +31.8% | -30.3% | +151.9% | -94.5% | |
| TTM Gross Profit | $1.34B | +0.0% | -1.8% | -10.4% | -18.9% | |
| Shares Outstanding | 26.74M | – | -1.2% | -8.0% | -10.2% |
TTM EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $27.92 | -70.4% | |
| 3Y | $27.92 | -70.4% | |
| 5Y | $220.48 | -96.3% | |
| All | $220.48 | -96.3% |
TTM EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$24.31 | +134.0% | |
| 3Y | -$76.20 | +110.8% | |
| 5Y | -$201.56 | +104.1% | |
| All | -$201.56 | +104.1% |
TTM EPS History
FAQ
- What is the current TTM EPS of BIO?
- As of today, BIO TTM EPS is $8.25
- What is BIO TTM EPS most recent change?
- BIO TTM EPS was up +35.87% on June 30, 2026
- What is 1-year change in BIO TTM EPS?
- BIO TTM EPS is down -29.66% year-over-year
- How far is BIO TTM EPS from its all-time high?
- BIO TTM EPS is currently -96.26% below its historical high of $220.48 set on September 30, 2021
- How does BIO TTM EPS rank versus sector peers?
- BIO TTM EPS is higher than 96.53% of companies in Healthcare sector
- How does the analyst estimate for BIO TTM EPS compare to its current value?
- Analysts estimate BIO TTM EPS at $23.18, +180.88% higher than the current value
- When is BIO next earnings release?
- The next earnings release for BIO is on
EPS Formula
EPS =
Data Sources & References
- BIO Official Website www.bio-rad.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/12208/000001220826000010/0000012208-26-000010-index.htm
- BIO Profile on Yahoo Finance finance.yahoo.com/quote/BIO
- BIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bio
